Schedule of Share-based Compensation, Allocation of Recognized Period Costs |
The
following table summarizes stock-based compensation recognized for the three and six months ended June 30, 2023 and 2022 for our employee
and director stock options.
Schedule of Share-based Compensation, Allocation of Recognized Period Costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
Stock Options |
|
June
30, |
|
|
June
30, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Employee Stock Options |
|
$ |
93,000 |
|
|
$ |
86,000 |
|
|
$ |
179,000 |
|
|
$ |
172,000 |
|
Director Stock Options |
|
|
32,000 |
|
|
|
17,000 |
|
|
|
64,000 |
|
|
|
33,000 |
|
Total |
|
$ |
125,000 |
|
|
$ |
103,000 |
|
|
$ |
243,000 |
|
|
$ |
205,000 |
|
|
Schedule of Stock Options Roll Forward |
The
summary of the Company’s total Stock Option Plans as of June 30, 2023, and June 30, 2022, and changes during the periods then ended,
are presented below. The Company’s Plans consist of the 2017 Plan and the 2003 Outside Directors Stock Plan (the “2003 Plan”):
Schedule of Stock Options Roll Forward
|
|
Shares |
|
|
Weighted
Average Exercise Price |
|
|
Weighted
Average Remaining Contractual Term (years) |
|
|
Aggregate Intrinsic
Value (2)
|
|
Options outstanding January 1, 2023 |
|
|
1,018,400 |
|
|
$ |
5.02 |
|
|
|
|
|
|
|
-
|
|
Granted |
|
|
295,000 |
|
|
$ |
3.95 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(265,600 |
) |
|
$ |
3.70 |
|
|
|
|
|
|
$ |
2,002,502 |
|
Forfeited/expired/cancelled |
|
|
(64,500 |
) |
|
$ |
3.67 |
|
|
|
|
|
|
|
|
|
Options outstanding end
of period (1) |
|
|
983,300 |
|
|
$ |
5.15 |
|
|
|
4.9 |
|
|
$ |
5,734,647 |
|
Options exercisable at
June 30, 2023(1) |
|
|
278,300 |
|
|
$ |
4.75 |
|
|
|
3.4 |
|
|
$ |
1,732,347 |
|
|
|
Shares |
|
|
Weighted
Average Exercise Price |
|
|
Weighted
Average Remaining Contractual Term (years) |
|
|
Aggregate Intrinsic
Value (2)
|
|
Options outstanding January 1, 2022 |
|
|
1,019,400 |
|
|
$ |
4.91 |
|
|
|
|
|
|
|
- |
|
Granted |
|
|
— |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(50,000 |
) |
|
$ |
3.97 |
|
|
|
|
|
|
$ |
98,000 |
|
Forfeited/expired/cancelled |
|
|
— |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
Options outstanding end
of period (1) |
|
|
969,400 |
|
|
$ |
4.96 |
|
|
|
3.7 |
|
|
$ |
883,991 |
|
Options exercisable at
June 30, 2022(1) |
|
|
405,900 |
|
|
$ |
3.91 |
|
|
|
2.5 |
|
|
$ |
577,276 |
|
(1) |
Options with exercise prices ranging from $2.79 to $7.50
|
(2) |
The intrinsic value of a stock option is the amount by
which the market value of the underlying stock exceeds the exercise price. |
|